NiKang Therapeutics Inc. Press Releases - EIN Presswire - Press Release Distribution Service

Published on April 5, 2021 - 06:37 GMT

NiKang Therapeutics Appoints Kelsey Chen, Ph.D., MBA, as Chief Financial Officer

WILMINGTON, DE, UNITED STATES, April 5, 2021 /⁨EINPresswire.com⁩/ -- NiKang Therapeutics Inc. (“NiKang”), a clinical stage biotech company focused on developing innovative small molecule oncology medicines to help patients with unmet medical needs, today …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on January 28, 2021 - 07:39 GMT

NiKang Therapeutics Appoints Gary Yeung, CFA, to Board of Directors

WILMINGTON, DE, UNITED STATES, January 28, 2021 /⁨EINPresswire.com⁩/ -- NiKang Therapeutics, Inc. (“NiKang”), a biotech company focused on discovering and developing innovative small molecule therapeutics to help patients with unmet medical needs, today …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on September 14, 2020 - 07:29 GMT

NiKang Therapeutics Completes $50 Million Series B Financing

Funds will support advancing lead programs into the clinic and expanding the company’s pipeline. This financing round is led by RTW Investments, LP. WILMINGTON, DELAWARE, UNITED STATES, September 14, 2020 /⁨EINPresswire.com⁩/ -- NiKang Therapeutics, Inc. …

Distribution channels: Healthcare & Pharmaceuticals Industry ...